Published in Ann Clin Microbiol Antimicrob on September 08, 2006
Voriconazole pharmacokinetics and pharmacodynamics in children. Clin Infect Dis (2010) 3.26
Melanized fungi in human disease. Clin Microbiol Rev (2010) 2.89
Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients. Antimicrob Agents Chemother (2010) 1.08
New insights into 1-aminocyclopropane-1-carboxylate (ACC) deaminase phylogeny, evolution and ecological significance. PLoS One (2014) 0.93
Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review. Medicine (Baltimore) (2015) 0.79
[Invasive mycoses and trauma]. Wien Med Wochenschr (2007) 0.75
Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis (2002) 2.70
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob Agents Chemother (2004) 2.08
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J (2002) 1.97
Hyalohyphomycosis and phaeohyphomycosis: two global disease entities of public health importance. Eur J Epidemiol (1986) 1.61
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis (2003) 1.53
Phaeohyphomycosis. Dermatol Clin (1996) 1.49
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med Mycol (2001) 1.35
Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Med Mycol (2002) 1.20
Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann Hematol (2003) 1.07
Emergence of black moulds in fungal disease: epidemiology and therapy. Curr Opin Infect Dis (2001) 1.04
Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery. Mycoses (2003) 1.02
Posttraumatic gas-containing brain abscess caused by Clostridium perfringens with unique simultaneous fungal suppuration by Myceliophthora thermophila: case report. Neurosurgery (1996) 0.86
The efficacy and safety of terbinafine in children. J Eur Acad Dermatol Venereol (2003) 0.86
Fatal disseminated infection caused by Myceliophthora thermophila, a new agent of mycosis: case history and laboratory characteristics. J Clin Microbiol (1992) 0.84
Fatal aortic Myceliophthora thermophila infection in a patient affected by cystic medial necrosis. Med Mycol (1998) 0.81
Survival after treatment of rabies with induction of coma. N Engl J Med (2005) 4.95
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol (2004) 4.70
Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med (2012) 3.26
Melanized fungi in human disease. Clin Microbiol Rev (2010) 2.89
Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis (2002) 2.70
Infections caused by Scedosporium spp. Clin Microbiol Rev (2008) 2.69
Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis (2003) 2.62
Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol (2007) 2.57
Sequence-based identification of filamentous basidiomycetous fungi from clinical specimens: a cautionary note. J Clin Microbiol (2009) 2.44
Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma. J Trauma Acute Care Surg (2012) 2.28
Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol (2008) 2.16
Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection. Pediatr Infect Dis J (2010) 2.07
Virology, immunology and pathology of human rabies during treatment. Pediatr Infect Dis J (2015) 2.06
Phylogenetic diversity and microsphere array-based genotyping of human pathogenic Fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006. J Clin Microbiol (2007) 2.02
Members of the Fusarium solani species complex that cause infections in both humans and plants are common in the environment. J Clin Microbiol (2006) 1.99
Species of Phaeoacremonium associated with infections in humans and environmental reservoirs in infected woody plants. J Clin Microbiol (2005) 1.98
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection. Antimicrob Agents Chemother (2007) 1.94
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother (2007) 1.85
Development and validation of a high-performance liquid chromatography assay for voriconazole. Antimicrob Agents Chemother (2003) 1.77
Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients. Antimicrob Agents Chemother (2011) 1.77
Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol (2007) 1.66
Disseminated Geosmithia argillacea infection in a German shepherd dog. Med Mycol (2009) 1.62
Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a Children's Hospital. Pediatrics (2003) 1.56
Increasing antiretroviral drug access for children with HIV infection. Pediatrics (2007) 1.54
Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) (2002) 1.53
Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol (2010) 1.51
Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum. Antimicrob Agents Chemother (2012) 1.51
Clostridium difficile infection in infants and children. Pediatrics (2012) 1.48
A two-locus DNA sequence database for typing plant and human pathogens within the Fusarium oxysporum species complex. Fungal Genet Biol (2009) 1.41
Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*. Pediatr Crit Care Med (2014) 1.41
Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species. Rev Iberoam Micol (2010) 1.40
Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. Clin Infect Dis (2011) 1.39
Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis (2002) 1.27
Phialosimplex, a new anamorphic genus associated with infections in dogs and having phylogenetic affinity to the Trichocomaceae. Med Mycol (2010) 1.24
Taxonomy and phylogeny of the Fusarium dimerum species group. Mycologia (2009) 1.24
Novel multilocus sequence typing scheme reveals high genetic diversity of human pathogenic members of the Fusarium incarnatum-F. equiseti and F. chlamydosporum species complexes within the United States. J Clin Microbiol (2009) 1.22
Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med (2011) 1.19
One fungus, one name: defining the genus Fusarium in a scientifically robust way that preserves longstanding use. Phytopathology (2013) 1.19
Adiaspiromycosis causing respiratory failure and a review of human infections due to Emmonsia and Chrysosporium spp. J Clin Microbiol (2012) 1.18
Whole genome sequence typing to investigate the Apophysomyces outbreak following a tornado in Joplin, Missouri, 2011. PLoS One (2012) 1.16
Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis. J Clin Microbiol (2009) 1.14
Incidence and risk factors for venous thromboembolism in critically ill children after trauma. J Trauma (2010) 1.14
Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs. J Clin Microbiol (2013) 1.11
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi. Med Mycol (2005) 1.11
Fungal endophthalmitis caused by Aspergillus ustus in a patient following cataract surgery. Med Mycol (2006) 1.10
Introduction of a Novel Swine-Origin Influenza A (H1N1) Virus into Milwaukee, Wisconsin in 2009. Viruses (2009) 1.09
Two new species of Mucor from clinical samples. Med Mycol (2010) 1.05
Prevention of necrotizing enterocolitis with probiotics. Pediatrics (2005) 1.04
Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology (2003) 1.02
Phylogenetic findings suggest possible new habitat and routes of infection of human eumyctoma. PLoS Negl Trop Dis (2013) 1.01
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob Agents Chemother (2009) 1.00
Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WI. Viruses (2010) 1.00
Phialemonium: an emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infection. Clin Infect Dis (2004) 0.99
Assent for treatment: clinician knowledge, attitudes, and practice. Pediatrics (2006) 0.99
Overview: infection during pregnancy and neurologic outcome in the child. Ment Retard Dev Disabil Res Rev (2002) 0.98
Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa. J Infect Dis (2002) 0.98
In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization. Antimicrob Agents Chemother (2003) 0.98
Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics (2003) 0.98
Fatal Actinomucor elegans var. kuwaitiensis infection following combat trauma. J Clin Microbiol (2009) 0.97
Paecilomyces lilacinus vaginitis in an immuno-competent patient. Emerg Infect Dis (2003) 0.97
Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease. Pediatr Infect Dis J (2007) 0.97
In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species. J Antimicrob Chemother (2009) 0.96
Metabolomics of cerebrospinal fluid from humans treated for rabies. J Proteome Res (2012) 0.95
In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole. Antimicrob Agents Chemother (2012) 0.95
Intrauterine exposure to infection and risk of cerebral palsy in very preterm infants. Arch Pediatr Adolesc Med (2003) 0.95
Serum 25-hydroxyvitamin D concentration does not correlate with atopic dermatitis severity. J Am Acad Dermatol (2013) 0.94
Impact of new antifungal breakpoints on antifungal resistance in Candida species. J Clin Microbiol (2014) 0.94
Mycoplasma hominis and Ureaplasma species brain abscess in a neonate. Pediatr Infect Dis J (2002) 0.93
Exophiala spinifera as a cause of cutaneous phaeohyphomycosis: case study and review of the literature. Med Mycol (2008) 0.93
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles. J Clin Microbiol (2002) 0.93
Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: case report and review of the literature. J Clin Microbiol (2002) 0.93
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum. Antimicrob Agents Chemother (2008) 0.93
Molecular identification and antifungal susceptibility testing of clinical isolates of the Candida rugosa species complex and proposal of the new species Candida neorugosa. J Clin Microbiol (2012) 0.92
Gradenigo syndrome: a rare but serious complication of otitis media. Pediatr Emerg Care (2005) 0.92
Failure of the Milwaukee protocol in a child with rabies. Clin Infect Dis (2011) 0.91
Phialemoniopsis, a new genus of Sordariomycetes, and new species of Phialemonium and Lecythophora. Mycologia (2012) 0.91
Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea. Scand J Infect Dis (2009) 0.91
Pythium aphanidermatum infection following combat trauma. J Clin Microbiol (2011) 0.91
Effects of trunk position on back surface-contour measured by raster stereophotography. Am J Orthop (Belle Mead NJ) (2002) 0.90
In vitro activities of free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis at various saprobic stages. Antimicrob Agents Chemother (2002) 0.90
A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid. Antimicrob Agents Chemother (2013) 0.89
Pilot study of antibiotic cycling in a pediatric intensive care unit. Crit Care Med (2002) 0.89
Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors. Antimicrob Agents Chemother (2008) 0.89
Resistant Candida parapsilosis associated with long term fluconazole prophylaxis in an animal model. Pediatr Infect Dis J (2004) 0.89
Disseminated human conidiobolomycosis due to Conidiobolus lamprauges. J Clin Microbiol (2010) 0.89
Cutaneous phaeohyphomycosis caused by Paraconiothyrium cyclothyrioides. J Clin Microbiol (2012) 0.89
Cutaneous infection caused by Macrophomina phaseolina in a child with acute myeloid leukemia. J Clin Microbiol (2009) 0.88
Effect of volume resuscitation on regional perfusion in dehydrated pediatric patients as measured by two-site near-infrared spectroscopy. Pediatr Emerg Care (2009) 0.87
Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice. Antimicrob Agents Chemother (2010) 0.87
Persistent pulmonary infection with an azole-resistant Coccidioides species. Med Mycol (2008) 0.87
Nosocomial outbreak of Exophiala jeanselmei fungemia associated with contamination of hospital water. Clin Infect Dis (2002) 0.87
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole. Med Mycol (2008) 0.87
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense. Antimicrob Agents Chemother (2013) 0.87